Conor McNamara
Stock Analyst at RBC Capital
(1.14)
# 3,805
Out of 5,149 analysts
141
Total ratings
30.1%
Success rate
-13.34%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $56.99 | +28.09% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.69 | +35.50% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $207.04 | +23.16% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.73 | +73.41% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $103.37 | -55.50% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $75.46 | +15.29% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $8.78 | +93.62% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $129.56 | -2.75% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $280.19 | +45.97% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $282.36 | +44.85% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $123.06 | +65.77% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $508.10 | +25.37% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $204.01 | +22.54% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $21.48 | +183.99% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.10 | +70.73% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $56.99
Upside: +28.09%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.69
Upside: +35.50%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $207.04
Upside: +23.16%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.73
Upside: +73.41%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $103.37
Upside: -55.50%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $75.46
Upside: +15.29%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.78
Upside: +93.62%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $129.56
Upside: -2.75%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $280.19
Upside: +45.97%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $282.36
Upside: +44.85%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $123.06
Upside: +65.77%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $508.10
Upside: +25.37%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $204.01
Upside: +22.54%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $21.48
Upside: +183.99%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.10
Upside: +70.73%